Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-02-21 17:14:28 UTC |
---|
HMDB ID | HMDB0000034 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Adenine |
---|
Description | Adenine, also known as 6-aminopurine or Ade, belongs to the class of organic compounds known as 6-aminopurines. These are purines that carry an amino group at position 6. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. Adenine forms adenosine, a nucleoside, when attached to ribose, and deoxyadenosine when attached to deoxyribose, and it forms adenosine triphosphate (ATP), a nucleotide, when three phosphate groups are added to adenosine. Adenine is a drug which is used for nutritional supplementation, also for treating dietary shortage or imbalance. Adenine is a strong basic compound (based on its pKa). Adenosine triphosphate is used in cellular metabolism as one of the basic methods of transferring chemical energy between reactions. Adenine exists in all living species, ranging from bacteria to humans. In individuals suspected of suffering from a supraventricular tachycardia (SVT), adenosine is used to help identify the rhythm. In humans, adenine is involved in riboflavin metabolism. Adenine is a potentially toxic compound. Adenine (sometimes known as vitamin B4) combines with the sugar ribose to form adenosine, which in turn can be bonded with from one to three phosphoric acid units, yielding AMP, ADP and ATP . A modified form of adenosine monophosphate (cyclic AMP) is an imporant secondary messenger in the propagation of many hormonal stimuli. Adenine is an integral part of the structure of many coenzymes. Adenine is one of four nitrogenous bases utilized in the synthesis of nucleic acids. Certain SVTs can be successfully terminated with adenosine. Adenosine (adenine with a ribose group) causes transient heart block in the AV node of the heart. These adenine derivatives perform important functions in cellular metabolism. Adenine forms adenosine, a nucleoside, when attached to ribose, and deoxyadenosine when attached to deoxyribose, and it forms adenosine triphosphate (ATP), which drives many cellular metabolic processes by transferring chemical energy between reactions. |
---|
Structure | InChI=1S/C5H5N5/c6-4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H3,6,7,8,9,10) |
---|
Synonyms | Value | Source |
---|
6-Aminopurine | ChEBI | A | ChEBI | Ade | ChEBI | Adenin | ChEBI | Leucon | Kegg | 1,6-Dihydro-6-iminopurine | HMDB | 1H-Purin-6-amine | HMDB | 1H-Purine-6-amine | HMDB | 3,6-Dihydro-6-iminopurine | HMDB | 6-Amino-1H-purine | HMDB | 6-Amino-3H-purine | HMDB | 6-Amino-7H-purine | HMDB | 6-Amino-9H-purine | HMDB | 6-Amino-purine | HMDB | 9H-Purin-6-amine | HMDB | 9H-Purin-6-yl-amin | HMDB | 9H-Purin-6-ylamine | HMDB | 9H-Purine-6-amine | HMDB | Adeninimine | HMDB | Vitamin b4 | HMDB | Vitamin b 4 | HMDB | 4, Vitamin b | HMDB | b 4, Vitamin | HMDB |
|
---|
Chemical Formula | C5H5N5 |
---|
Average Molecular Weight | 135.1267 |
---|
Monoisotopic Molecular Weight | 135.054495185 |
---|
IUPAC Name | 7H-purin-6-amine |
---|
Traditional Name | vitamin B4 |
---|
CAS Registry Number | 73-24-5 |
---|
SMILES | NC1=C2NC=NC2=NC=N1 |
---|
InChI Identifier | InChI=1S/C5H5N5/c6-4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H3,6,7,8,9,10) |
---|
InChI Key | GFFGJBXGBJISGV-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 6-aminopurines. These are purines that carry an amino group at position 6. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Imidazopyrimidines |
---|
Sub Class | Purines and purine derivatives |
---|
Direct Parent | 6-aminopurines |
---|
Alternative Parents | |
---|
Substituents | - 6-aminopurine
- Aminopyrimidine
- Imidolactam
- Pyrimidine
- Heteroaromatic compound
- Imidazole
- Azole
- Azacycle
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Primary amine
- Organonitrogen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 360 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 1.03 mg/mL | Not Available | LogP | -0.09 | HANSCH,C ET AL. (1995) |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Adenine,1TMS,isomer #1 | C[Si](C)(C)NC1=NC=NC2=C1[NH]C=N2 | 1933.0 | Semi standard non polar | 33892256 | Adenine,1TMS,isomer #1 | C[Si](C)(C)NC1=NC=NC2=C1[NH]C=N2 | 1796.1 | Standard non polar | 33892256 | Adenine,1TMS,isomer #1 | C[Si](C)(C)NC1=NC=NC2=C1[NH]C=N2 | 2924.8 | Standard polar | 33892256 | Adenine,1TMS,isomer #2 | C[Si](C)(C)N1C=NC2=NC=NC(N)=C21 | 1870.7 | Semi standard non polar | 33892256 | Adenine,1TMS,isomer #2 | C[Si](C)(C)N1C=NC2=NC=NC(N)=C21 | 1757.9 | Standard non polar | 33892256 | Adenine,1TMS,isomer #2 | C[Si](C)(C)N1C=NC2=NC=NC(N)=C21 | 2680.3 | Standard polar | 33892256 | Adenine,2TMS,isomer #1 | C[Si](C)(C)N(C1=NC=NC2=C1[NH]C=N2)[Si](C)(C)C | 1864.6 | Semi standard non polar | 33892256 | Adenine,2TMS,isomer #1 | C[Si](C)(C)N(C1=NC=NC2=C1[NH]C=N2)[Si](C)(C)C | 1887.7 | Standard non polar | 33892256 | Adenine,2TMS,isomer #1 | C[Si](C)(C)N(C1=NC=NC2=C1[NH]C=N2)[Si](C)(C)C | 2578.7 | Standard polar | 33892256 | Adenine,2TMS,isomer #2 | C[Si](C)(C)NC1=NC=NC2=C1N([Si](C)(C)C)C=N2 | 1941.3 | Semi standard non polar | 33892256 | Adenine,2TMS,isomer #2 | C[Si](C)(C)NC1=NC=NC2=C1N([Si](C)(C)C)C=N2 | 1790.1 | Standard non polar | 33892256 | Adenine,2TMS,isomer #2 | C[Si](C)(C)NC1=NC=NC2=C1N([Si](C)(C)C)C=N2 | 2569.4 | Standard polar | 33892256 | Adenine,3TMS,isomer #1 | C[Si](C)(C)N(C1=NC=NC2=C1N([Si](C)(C)C)C=N2)[Si](C)(C)C | 1902.4 | Semi standard non polar | 33892256 | Adenine,3TMS,isomer #1 | C[Si](C)(C)N(C1=NC=NC2=C1N([Si](C)(C)C)C=N2)[Si](C)(C)C | 1901.4 | Standard non polar | 33892256 | Adenine,3TMS,isomer #1 | C[Si](C)(C)N(C1=NC=NC2=C1N([Si](C)(C)C)C=N2)[Si](C)(C)C | 2294.0 | Standard polar | 33892256 | Adenine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=NC=NC2=C1[NH]C=N2 | 2155.8 | Semi standard non polar | 33892256 | Adenine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=NC=NC2=C1[NH]C=N2 | 1950.7 | Standard non polar | 33892256 | Adenine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=NC=NC2=C1[NH]C=N2 | 3016.4 | Standard polar | 33892256 | Adenine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C=NC2=NC=NC(N)=C21 | 2123.8 | Semi standard non polar | 33892256 | Adenine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C=NC2=NC=NC(N)=C21 | 1938.3 | Standard non polar | 33892256 | Adenine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C=NC2=NC=NC(N)=C21 | 2772.8 | Standard polar | 33892256 | Adenine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=NC=NC2=C1[NH]C=N2)[Si](C)(C)C(C)(C)C | 2259.5 | Semi standard non polar | 33892256 | Adenine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=NC=NC2=C1[NH]C=N2)[Si](C)(C)C(C)(C)C | 2296.3 | Standard non polar | 33892256 | Adenine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=NC=NC2=C1[NH]C=N2)[Si](C)(C)C(C)(C)C | 2653.8 | Standard polar | 33892256 | Adenine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=NC=NC2=C1N([Si](C)(C)C(C)(C)C)C=N2 | 2352.6 | Semi standard non polar | 33892256 | Adenine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=NC=NC2=C1N([Si](C)(C)C(C)(C)C)C=N2 | 2198.6 | Standard non polar | 33892256 | Adenine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=NC=NC2=C1N([Si](C)(C)C(C)(C)C)C=N2 | 2684.7 | Standard polar | 33892256 | Adenine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=NC=NC2=C1N([Si](C)(C)C(C)(C)C)C=N2)[Si](C)(C)C(C)(C)C | 2486.1 | Semi standard non polar | 33892256 | Adenine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=NC=NC2=C1N([Si](C)(C)C(C)(C)C)C=N2)[Si](C)(C)C(C)(C)C | 2535.4 | Standard non polar | 33892256 | Adenine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=NC=NC2=C1N([Si](C)(C)C(C)(C)C)C=N2)[Si](C)(C)C(C)(C)C | 2528.6 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Adenine GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (2 TMS) | splash10-03di-3490000000-7efe9518c90307a43707 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Adenine GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (Non-derivatized) | splash10-03di-2690000000-6dc072eb8483a2c38e18 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Adenine GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (2 TMS) | splash10-00di-9350000000-220125189c286547e86c | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Adenine GC-MS (2 TMS) | splash10-03di-4690000000-2d327a6944df53411886 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Adenine GC-MS (1 TMS) | splash10-0006-3920000000-f488e8aa64272a07b3d9 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Adenine GC-MS (3 TMS) | splash10-000i-0329000000-0b012fa483ce8764d2af | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Adenine GC-EI-TOF (Non-derivatized) | splash10-03di-3490000000-7efe9518c90307a43707 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Adenine GC-EI-TOF (Non-derivatized) | splash10-03di-2690000000-6dc072eb8483a2c38e18 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Adenine GC-EI-TOF (Non-derivatized) | splash10-00di-9350000000-220125189c286547e86c | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Adenine GC-MS (Non-derivatized) | splash10-03di-4690000000-2d327a6944df53411886 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Adenine GC-MS (Non-derivatized) | splash10-0006-3920000000-f488e8aa64272a07b3d9 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Adenine GC-MS (Non-derivatized) | splash10-000i-0329000000-0b012fa483ce8764d2af | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Adenine GC-EI-TOF (Non-derivatized) | splash10-03di-2690000000-534edabc8ab24e32f3f5 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Adenine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a5i-9700000000-e85c2b0bb19cf3401e5a | 2016-09-22 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Adenine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-000i-6900000000-39944576233751576a91 | 2014-09-20 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Negative-QTOF | splash10-0a4i-0900000000-b24b09629456779d96e6 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Negative-QTOF | splash10-001i-0900000000-80808f34c7497219d349 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) 30V, Negative-QTOF | splash10-0a5c-6900000000-f6c0abd6d3fca61bd7f7 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine LC-ESI-ITFT , negative-QTOF | splash10-0a4i-0900000000-b24b09629456779d96e6 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine LC-ESI-QTOF , negative-QTOF | splash10-001i-0900000000-80808f34c7497219d349 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine LC-ESI-QTOF , negative-QTOF | splash10-0a5c-6900000000-f6c0abd6d3fca61bd7f7 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine , negative-QTOF | splash10-001i-0900000000-cbe0a995dab473351f43 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine , negative-QTOF | splash10-001i-0900000000-bfc42d662f222a7c16c7 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine 20V, Negative-QTOF | splash10-0a59-4900000000-099ee82fc2f658e1cd04 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine 10V, Negative-QTOF | splash10-001i-0900000000-c100f5ac716c497996be | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine 35V, Negative-QTOF | splash10-001i-0900000000-379c5c6ea7b1135677c6 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine 40V, Negative-QTOF | splash10-014i-9000000000-346f2325bf2e66e7a339 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine 35V, Negative-QTOF | splash10-001i-0900000000-87f60041335919c4a0de | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine 40V, Negative-QTOF | splash10-014l-9000000000-a71034da1c65738b37bd | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine 30V, Negative-QTOF | splash10-0a5c-6900000000-f6c0abd6d3fca61bd7f7 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine 10V, Negative-QTOF | splash10-001i-0900000000-090d369100e8edeb5145 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine 35V, Negative-QTOF | splash10-001i-0900000000-a56b3bd296195086b5d0 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine 10V, Negative-QTOF | splash10-001i-0900000000-a76f7f2350e82c676371 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine 35V, Negative-QTOF | splash10-053r-0900000000-4213d2fff3cdad674b8e | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine 20V, Negative-QTOF | splash10-0a59-0900000000-d0f2f3ccc46d430b6c3c | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine 40V, Negative-QTOF | splash10-0a4i-0900000000-bf20f302482d1cc4a27d | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine 20V, Negative-QTOF | splash10-0a59-3900000000-f4155217d6bcdbbcc17f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine 30V, Negative-QTOF | splash10-066u-9400000000-ada6d909e20e2184a05b | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-000i-0900000000-95d4894082ada0b24773 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Adenine Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-014i-5900000000-66b1c086d7a666b2d02b | 2012-07-24 | HMDB team, MONA | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm
- Extracellular
- Nucleus
- Lysosome
|
---|
Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
- Feces
- Saliva
- Urine
|
---|
Tissue Locations | - All Tissues
- Placenta
- Prostate
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.3 +/- 0.1 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.64 +/- 0.15 uM | Adult (>18 years old) | Both | Normal | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0 - 0.2 uM | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Normal | | details | Saliva | Detected and Quantified | 1.19 +/- 1.25 uM | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected and Quantified | 0.448 +/- 0.309 uM | Adult (>18 years old) | Female | Normal | | details | Saliva | Detected and Quantified | 1.15 +/- 0.93 uM | Adult (>18 years old) | Female | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.65 (0.52-0.85) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | - Geigy Scientific ...
- West Cadwell, N.J...
- Basel, Switzerlan...
| details | Urine | Detected and Quantified | 2.9 (1.4-5.1) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0-6 umol/mmol creatinine | Children (1 - 18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 1.17 umol/mmol creatinine | Adult (>18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 4.087 +/- 1.149 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | <0.1 umol/mmol creatinine | Infant (0-1 year old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 13-20 umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.5 +/- 0.3 uM | Adult (>18 years old) | Both | Solid tumors | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.5 (0 - 18.0) uM | Children (1-13 years old) | Not Specified | Meningitis | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.35 (0 - 23.4) uM | Children (1-13 years old) | Not Specified | Tuberculous meningitis | | details | Cerebrospinal Fluid (CSF) | Detected and Quantified | 0.96 (0 - 12.0) uM | Children (1-13 years old) | Not Specified | Meningitis | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Crohns disease | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Ulcerative colitis | | details | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Unclassified IBD | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Attachment loss | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Periodontal Probing Depth | | details | Saliva | Detected and Quantified | 1.03 +/- 0.73 uM | Adult (>18 years old) | Male | Alzheimer's disease | | details | Saliva | Detected and Quantified | 0.87 +/- 0.78 uM | Adult (>18 years old) | Male | Frontotemporal lobe dementia | | details | Saliva | Detected and Quantified | 0.37 +/- 0.21 uM | Adult (>18 years old) | Both | Lewy body disease | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Bladder cancer | | details | Urine | Detected and Quantified | 7.163 +/- 7.025 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Thymidine treatment |
---|
- Leyva A, Schornagel JH, Kraal I, Wadman SK, Pinedo HM: Clinical and biochemical studies of high-dose thymidine treatment in patients with solid tumors. J Cancer Res Clin Oncol. 1984;107(3):211-6. [PubMed:6736109 ]
| Meningitis |
---|
- Rodriguez-Nunez A, Cid E, Rodriguez-Garcia J, Camina F, Rodriguez-Segade S, Castro-Gago M: Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentrations in cerebrospinal fluid of children with meningitis. Brain Dev. 2003 Mar;25(2):102-6. [PubMed:12581805 ]
| Tuberculous meningitis |
---|
- Rodriguez-Nunez A, Cid E, Rodriguez-Garcia J, Camina F, Rodriguez-Segade S, Castro-Gago M: Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentrations in cerebrospinal fluid of children with meningitis. Brain Dev. 2003 Mar;25(2):102-6. [PubMed:12581805 ]
| Colorectal cancer |
---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| Crohn's disease |
---|
- Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158. [PubMed:27609529 ]
| Ulcerative colitis |
---|
- Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158. [PubMed:27609529 ]
| Alzheimer's disease |
---|
- Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013 Sep 6. [PubMed:23857558 ]
| Frontotemporal dementia |
---|
- Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013 Sep 6. [PubMed:23857558 ]
| Lewy body disease |
---|
- Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013 Sep 6. [PubMed:23857558 ]
| Attachment loss |
---|
- Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr 26. [PubMed:31026179 ]
| Periodontal Probing Depth |
---|
- Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr 26. [PubMed:31026179 ]
| Eosinophilic esophagitis |
---|
- Slae, M., Huynh, H., Wishart, D.S. (2014). Analysis of 30 normal pediatric urine samples via NMR spectroscopy (unpublished work). NA.
|
|
---|
Associated OMIM IDs | |
---|
External Links |
---|
DrugBank ID | DB00173 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB012266 |
---|
KNApSAcK ID | C00001490 |
---|
Chemspider ID | 185 |
---|
KEGG Compound ID | C00147 |
---|
BioCyc ID | ADENINE |
---|
BiGG ID | 34039 |
---|
Wikipedia Link | Adenine |
---|
METLIN ID | 85 |
---|
PubChem Compound | 190 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 16708 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | ADE |
---|
MarkerDB ID | MDB00000017 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Baddiley, J.; Lythgoe, B.; Todd, A. R. Synthesis of purine nucleosides. II. A new and convenient synthesis of adenine. Journal of the Chemical Society (1943), 386-7. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Di Pietro V, Perruzza I, Amorini AM, Balducci A, Ceccarelli L, Lazzarino G, Barsotti P, Giardina B, Tavazzi B: Clinical, biochemical and molecular diagnosis of a compound homozygote for the 254 bp deletion-8 bp insertion of the APRT gene suffering from severe renal failure. Clin Biochem. 2007 Jan;40(1-2):73-80. Epub 2006 Oct 19. [PubMed:17126311 ]
- Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762. [PubMed:19212411 ]
- Eells JT, Spector R: Purine and pyrimidine base and nucleoside concentrations in human cerebrospinal fluid and plasma. Neurochem Res. 1983 Nov;8(11):1451-7. [PubMed:6656991 ]
- Moriyama H, Iizuka T, Nagai M, Hoshi K: Adenine, an inhibitor of platelet aggregation, from the leaves of Cassia alata. Biol Pharm Bull. 2003 Sep;26(9):1361-4. [PubMed:12951489 ]
- Liu Y, Xu G, Xu C, Garcia L, Lin CC, Yeh LT: Ultra sensitive method for the determination of 9-(2-phosphonylmethoxyethyl)adenine in human serum by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Apr 25;803(2):293-8. [PubMed:15063338 ]
- Terry KL, De Vivo I, Titus-Ernstoff L, Shih MC, Cramer DW: Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk. Cancer Res. 2005 Jul 1;65(13):5974-81. [PubMed:15994977 ]
- Steiner MC, Evans R, Deacon SJ, Singh SJ, Patel P, Fox J, Greenhaff PL, Morgan MD: Adenine nucleotide loss in the skeletal muscles during exercise in chronic obstructive pulmonary disease. Thorax. 2005 Nov;60(11):932-6. Epub 2005 Jul 29. [PubMed:16055624 ]
- Whitehead JW, Lee GP, Gharagozloo P, Hofer P, Gehrig A, Wintergerst P, Smyth D, McCoull W, Hachicha M, Patel A, Kyle DJ: 8-Substituted analogues of 3-(3-cyclopentyloxy-4-methoxy-benzyl)-8-isopropyl-adenine: highly potent and selective PDE4 inhibitors. J Med Chem. 2005 Feb 24;48(4):1237-43. [PubMed:15715490 ]
- Reimers HJ, Packham MA, Mustard JF: Labeling of the releasable adenine nucleotides of washed human platelets. Blood. 1977 Jan;49(1):89-99. [PubMed:401462 ]
- Hartmann S, Okun JG, Schmidt C, Langhans CD, Garbade SF, Burgard P, Haas D, Sass JO, Nyhan WL, Hoffmann GF: Comprehensive detection of disorders of purine and pyrimidine metabolism by HPLC with electrospray ionization tandem mass spectrometry. Clin Chem. 2006 Jun;52(6):1127-37. Epub 2006 Apr 13. [PubMed:16613999 ]
- Ohdoi C, Nyhan WL, Kuhara T: Chemical diagnosis of Lesch-Nyhan syndrome using gas chromatography-mass spectrometry detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 15;792(1):123-30. [PubMed:12829005 ]
- Ruiz-Stewart I, Kazerounian S, Pitari GM, Schulz S, Waldman SA: Soluble guanylate cyclase is allosterically inhibited by direct interaction with 2-substituted adenine nucleotides. Eur J Biochem. 2002 Apr;269(8):2186-93. [PubMed:11985597 ]
- Rolfes RJ: Regulation of purine nucleotide biosynthesis: in yeast and beyond. Biochem Soc Trans. 2006 Nov;34(Pt 5):786-90. [PubMed:17052198 ]
- Simoni RE, Gomes LN, Scalco FB, Oliveira CP, Aquino Neto FR, de Oliveira ML: Uric acid changes in urine and plasma: an effective tool in screening for purine inborn errors of metabolism and other pathological conditions. J Inherit Metab Dis. 2007 Jun;30(3):295-309. Epub 2007 May 19. [PubMed:17520339 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
---|